Cangene's structure and diverse technology base provides flexibility
when responding to the ever changing biotechnology industry. Cangene
is focused on its core strengths;
Hyperimmunes
Manufacturing specialty plasma-based products. Antibodies purified
from human plasma for therapeutic and preventative uses.
Contract Manufacturing
Providing cGMP-manufacturing services. Offering start-to-finish manufacturing ranging from research and product development, through fermentation and purification to final formulation, fill and finishing.
Bio-Defense
Supplying biodefense products to support the stockpile programs of governments worldwide.
WHAT: Q2 Earnings Announcement WHEN: 2008-03-14 10:00 ET English Event
To Learn More About the Role of WinRho SDF in the Management of ITP, click on this link
